|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/50 | |
| G01N 33/68 | |||
| G01N 33/53 | |||
| A61K 38/17 | |||
| C07D 473/34 | |||
| A61P 35/00 | |||
| G01N 33/574 |
| (11) | Patento numeris | 2614369 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11824247.8 |
| Europos patento paraiškos padavimo data | 2011-09-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-07-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/051258 |
| Data | 2011-09-12 |
| (87) | Numeris | WO 2012/034132 |
| Data | 2012-03-15 |
| (30) | Numeris | Data | Šalis |
| 381684 P | 2010-09-10 | US |
| (72) |
COPELAND, Robert Allen, US
RICHON, Victoria Marie, US
SCOTT, Margaret Davis, US
SNEERINGER, Christopher John, US
KUNTZ, Kevin Wayne, US
KNUTSON, Sarah Kathleen, US
POLLOCK, Roy Macfarlane, US
|
| (73) |
Epizyme, Inc.,
400 Technology Square, 4th Floor, Cambridge, MA 02139,
US
|
| (54) | METHOD FOR DETERMINING THE SUITABILITY OF INHIBITORS OF HUMAN EZH2 IN TREATMENT |
| METHOD FOR DETERMINING THE SUITABILITY OF INHIBITORS OF HUMAN EZH2 IN TREATMENT |